Group Holdings (Sbs) Advis Tpg Sells 33,412 Shares of Progyny Inc (NASDAQ:PGNY) Stock

Progyny Inc (NASDAQ:PGNY) major shareholder Group Holdings (Sbs) Advis Tpg sold 33,412 shares of the company’s stock in a transaction dated Wednesday, July 8th. The shares were sold at an average price of $25.71, for a total transaction of $859,022.52. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Group Holdings (Sbs) Advis Tpg also recently made the following trade(s):

  • On Thursday, July 2nd, Group Holdings (Sbs) Advis Tpg sold 66,381 shares of Progyny stock. The shares were sold at an average price of $26.27, for a total transaction of $1,743,828.87.
  • On Monday, July 6th, Group Holdings (Sbs) Advis Tpg sold 110,000 shares of Progyny stock. The shares were sold at an average price of $26.43, for a total transaction of $2,907,300.00.
  • On Tuesday, June 23rd, Group Holdings (Sbs) Advis Tpg sold 70,000 shares of Progyny stock. The shares were sold at an average price of $24.93, for a total transaction of $1,745,100.00.
  • On Tuesday, June 9th, Group Holdings (Sbs) Advis Tpg sold 180,000 shares of Progyny stock. The stock was sold at an average price of $24.74, for a total transaction of $4,453,200.00.
  • On Thursday, May 28th, Group Holdings (Sbs) Advis Tpg sold 9,648 shares of Progyny stock. The stock was sold at an average price of $25.12, for a total transaction of $242,357.76.
  • On Friday, May 15th, Group Holdings (Sbs) Advis Tpg sold 120,000 shares of Progyny stock. The stock was sold at an average price of $24.69, for a total transaction of $2,962,800.00.
  • On Tuesday, May 5th, Group Holdings (Sbs) Advis Tpg sold 67,304 shares of Progyny stock. The stock was sold at an average price of $22.70, for a total transaction of $1,527,800.80.

NASDAQ PGNY opened at $26.81 on Friday. The firm’s 50 day moving average price is $24.71 and its 200-day moving average price is $25.37. Progyny Inc has a 52-week low of $13.29 and a 52-week high of $36.50. The company has a market cap of $2.22 billion and a PE ratio of 243.73.

Progyny (NASDAQ:PGNY) last released its quarterly earnings data on Tuesday, May 12th. The company reported $0.04 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.02 by $0.02. The business had revenue of $81.02 million for the quarter, compared to the consensus estimate of $71.81 million. The company’s revenue was up 71.7% compared to the same quarter last year. As a group, equities research analysts expect that Progyny Inc will post 0.17 earnings per share for the current year.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Citigroup Inc. lifted its position in Progyny by 45.3% during the first quarter. Citigroup Inc. now owns 3,381 shares of the company’s stock valued at $72,000 after acquiring an additional 1,054 shares during the last quarter. Advisor Group Inc. purchased a new stake in Progyny during the fourth quarter valued at approximately $39,000. Bank of Montreal Can purchased a new stake in Progyny during the fourth quarter valued at approximately $40,000. Ladenburg Thalmann Financial Services Inc. purchased a new stake in Progyny during the fourth quarter valued at approximately $46,000. Finally, Victory Capital Management Inc. purchased a new stake in Progyny during the fourth quarter valued at approximately $50,000. Hedge funds and other institutional investors own 38.03% of the company’s stock.

A number of brokerages have commented on PGNY. Citigroup dropped their target price on shares of Progyny from $29.00 to $28.00 and set a “buy” rating on the stock in a research note on Wednesday, May 13th. SVB Leerink began coverage on shares of Progyny in a research note on Wednesday, July 1st. They issued an “outperform” rating and a $35.00 target price on the stock. Guggenheim began coverage on shares of Progyny in a research note on Tuesday, June 2nd. They issued a “buy” rating and a $30.00 target price on the stock. Finally, Zacks Investment Research downgraded shares of Progyny from a “buy” rating to a “hold” rating in a research note on Friday, May 1st. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $29.86.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.

See Also: Sell-Side Analysts

Insider Buying and Selling by Quarter for Progyny (NASDAQ:PGNY)

Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.